25 XP   0   0   10

Abnova Taiwan Corp
Buy, Hold or Sell?

Let's analyse Abnova together

PenkeI guess you are interested in Abnova Taiwan Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Abnova Taiwan Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Abnova Taiwan Corp

I send you an email if I find something interesting about Abnova Taiwan Corp.

Quick analysis of Abnova (30 sec.)










What can you expect buying and holding a share of Abnova? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
67.5%

What is your share worth?

Current worth
NT$21.24
Expected worth in 1 year
NT$21.15
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
NT$-0.09
Return On Investment
-0.3%

For what price can you sell your share?

Current Price per Share
NT$31.15
Expected price per share
NT$29.80 - NT$32.60
How sure are you?
50%

1. Valuation of Abnova (5 min.)




Live pricePrice per Share (EOD)

NT$31.15

Intrinsic Value Per Share

NT$-24.72 - NT$-7.33

Total Value Per Share

NT$-3.48 - NT$13.91

2. Growth of Abnova (5 min.)




Is Abnova growing?

Current yearPrevious yearGrowGrow %
How rich?$39.4m$37.9m$1m2.7%

How much money is Abnova making?

Current yearPrevious yearGrowGrow %
Making money$335.2k$574.4k-$239.1k-71.4%
Net Profit Margin11.4%18.3%--

How much money comes from the company's main activities?

3. Financial Health of Abnova (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#497 / 1010

Most Revenue
#401 / 1010

Most Profit
#155 / 1010

Most Efficient
#104 / 1010

What can you expect buying and holding a share of Abnova? (5 min.)

Welcome investor! Abnova's management wants to use your money to grow the business. In return you get a share of Abnova.

What can you expect buying and holding a share of Abnova?

First you should know what it really means to hold a share of Abnova. And how you can make/lose money.

Speculation

The Price per Share of Abnova is NT$31.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abnova.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abnova, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$21.24. Based on the TTM, the Book Value Change Per Share is NT$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abnova.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.010.0%0.010.0%0.010.0%0.000.0%0.010.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.010.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.020.1%0.010.0%0.010.0%
Usd Price Per Share1.08-1.07-1.21-1.35-1.24-
Price to Earnings Ratio49.26-48.38-35.43-81.10-83.56-
Price-to-Total Gains Ratio365.57-152.57-80.36-53.49-128.82-
Price to Book Ratio1.65-1.66-1.93-2.18-2.03-
Price-to-Total Gains Ratio365.57-152.57-80.36-53.49-128.82-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.956305
Number of shares1045
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.01
Gains per Quarter (1045 shares)-0.7511.00
Gains per Year (1045 shares)-3.0143.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3-1338634
20-6-16751378
30-9-1911319122
40-12-2215125166
50-15-2518931210
60-18-2822638254
70-21-3126444298
80-24-3430250342
90-27-3734056386
100-30-4037763430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%38.02.00.095.0%54.02.00.096.4%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%14.06.00.070.0%29.011.00.072.5%41.015.00.073.2%
Dividend per Share0.00.04.00.0%6.00.06.050.0%13.00.07.065.0%27.00.013.067.5%33.00.023.058.9%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%18.02.00.090.0%35.05.00.087.5%47.09.00.083.9%

Fundamentals of Abnova

About Abnova Taiwan Corp

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, lysates/slides, beads/dyes, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.

Fundamental data was last updated by Penke on 2024-04-16 21:58:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Abnova Taiwan Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Abnova earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Abnova to the Biotechnology industry mean.
  • A Net Profit Margin of 11.5% means that NT$0.11 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Abnova Taiwan Corp:

  • The MRQ is 11.5%. The company is making a huge profit. +2
  • The TTM is 11.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.5%TTM11.4%+0.1%
TTM11.4%YOY18.3%-6.9%
TTM11.4%5Y8.9%+2.6%
5Y8.9%10Y10.4%-1.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5%-207.2%+218.7%
TTM11.4%-216.8%+228.2%
YOY18.3%-282.3%+300.6%
5Y8.9%-436.8%+445.7%
10Y10.4%-597.3%+607.7%
1.1.2. Return on Assets

Shows how efficient Abnova is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abnova to the Biotechnology industry mean.
  • 0.8% Return on Assets means that Abnova generated NT$0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Abnova Taiwan Corp:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%+0.0%
TTM0.8%YOY1.4%-0.6%
TTM0.8%5Y0.7%+0.1%
5Y0.7%10Y0.9%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-13.3%+14.1%
TTM0.8%-12.8%+13.6%
YOY1.4%-11.6%+13.0%
5Y0.7%-13.8%+14.5%
10Y0.9%-15.6%+16.5%
1.1.3. Return on Equity

Shows how efficient Abnova is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abnova to the Biotechnology industry mean.
  • 0.8% Return on Equity means Abnova generated NT$0.01 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Abnova Taiwan Corp:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.9%0.0%
TTM0.9%YOY1.5%-0.7%
TTM0.9%5Y0.8%+0.1%
5Y0.8%10Y0.9%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-16.9%+17.7%
TTM0.9%-16.1%+17.0%
YOY1.5%-14.9%+16.4%
5Y0.8%-19.3%+20.1%
10Y0.9%-20.1%+21.0%

1.2. Operating Efficiency of Abnova Taiwan Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Abnova is operating .

  • Measures how much profit Abnova makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abnova to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Abnova Taiwan Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY15.6%-15.6%
TTM-5Y10.5%-10.5%
5Y10.5%10Y7.3%+3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY15.6%-288.4%+304.0%
5Y10.5%-486.2%+496.7%
10Y7.3%-628.4%+635.7%
1.2.2. Operating Ratio

Measures how efficient Abnova is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are NT$1.38 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Abnova Taiwan Corp:

  • The MRQ is 1.375. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.429. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.375TTM1.429-0.054
TTM1.429YOY1.353+0.076
TTM1.4295Y1.426+0.003
5Y1.42610Y1.163+0.264
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3753.235-1.860
TTM1.4293.310-1.881
YOY1.3533.838-2.485
5Y1.4265.679-4.253
10Y1.1637.823-6.660

1.3. Liquidity of Abnova Taiwan Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Abnova is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 14.69 means the company has NT$14.69 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Abnova Taiwan Corp:

  • The MRQ is 14.693. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.521. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.693TTM10.521+4.173
TTM10.521YOY10.824-0.304
TTM10.5215Y10.430+0.090
5Y10.43010Y7.554+2.877
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.6933.863+10.830
TTM10.5214.169+6.352
YOY10.8245.337+5.487
5Y10.4306.122+4.308
10Y7.5546.434+1.120
1.3.2. Quick Ratio

Measures if Abnova is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abnova to the Biotechnology industry mean.
  • A Quick Ratio of 0.63 means the company can pay off NT$0.63 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Abnova Taiwan Corp:

  • The MRQ is 0.630. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.483. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.630TTM0.483+0.147
TTM0.483YOY1.067-0.584
TTM0.4835Y0.831-0.348
5Y0.83110Y0.947-0.116
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6303.504-2.874
TTM0.4833.991-3.508
YOY1.0675.371-4.304
5Y0.8316.088-5.257
10Y0.9476.395-5.448

1.4. Solvency of Abnova Taiwan Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Abnova assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abnova to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that Abnova assets are financed with 5.1% credit (debt) and the remaining percentage (100% - 5.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Abnova Taiwan Corp:

  • The MRQ is 0.051. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.076. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.051TTM0.076-0.025
TTM0.076YOY0.066+0.011
TTM0.0765Y0.067+0.009
5Y0.06710Y0.067+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0510.339-0.288
TTM0.0760.337-0.261
YOY0.0660.271-0.205
5Y0.0670.368-0.301
10Y0.0670.388-0.321
1.4.2. Debt to Equity Ratio

Measures if Abnova is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abnova to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.4% means that company has NT$0.05 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Abnova Taiwan Corp:

  • The MRQ is 0.054. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.083. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.054TTM0.083-0.029
TTM0.083YOY0.070+0.013
TTM0.0835Y0.072+0.011
5Y0.07210Y0.072+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0540.392-0.338
TTM0.0830.403-0.320
YOY0.0700.335-0.265
5Y0.0720.427-0.355
10Y0.0720.461-0.389

2. Market Valuation of Abnova Taiwan Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Abnova generates.

  • Above 15 is considered overpriced but always compare Abnova to the Biotechnology industry mean.
  • A PE ratio of 49.26 means the investor is paying NT$49.26 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Abnova Taiwan Corp:

  • The EOD is 43.716. Based on the earnings, the company is overpriced. -1
  • The MRQ is 49.259. Based on the earnings, the company is overpriced. -1
  • The TTM is 48.382. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD43.716MRQ49.259-5.543
MRQ49.259TTM48.382+0.877
TTM48.382YOY35.432+12.950
TTM48.3825Y81.100-32.717
5Y81.10010Y83.562-2.462
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD43.716-2.300+46.016
MRQ49.259-2.656+51.915
TTM48.382-2.718+51.100
YOY35.432-4.145+39.577
5Y81.100-6.258+87.358
10Y83.562-6.315+89.877
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Abnova Taiwan Corp:

  • The EOD is -40.281. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -45.388. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 694.327. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-40.281MRQ-45.388+5.108
MRQ-45.388TTM694.327-739.716
TTM694.327YOY30.131+664.197
TTM694.3275Y184.428+509.899
5Y184.42810Y92.852+91.576
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-40.281-2.974-37.307
MRQ-45.388-3.306-42.082
TTM694.327-3.508+697.835
YOY30.131-5.613+35.744
5Y184.428-8.378+192.806
10Y92.852-8.873+101.725
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Abnova is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.65 means the investor is paying NT$1.65 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Abnova Taiwan Corp:

  • The EOD is 1.466. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.652. Based on the equity, the company is underpriced. +1
  • The TTM is 1.659. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.466MRQ1.652-0.186
MRQ1.652TTM1.659-0.007
TTM1.659YOY1.934-0.275
TTM1.6595Y2.182-0.523
5Y2.18210Y2.027+0.155
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4661.914-0.448
MRQ1.6522.116-0.464
TTM1.6592.097-0.438
YOY1.9342.881-0.947
5Y2.1823.550-1.368
10Y2.0273.936-1.909
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Abnova Taiwan Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.096-0.023+124%0.331-71%0.049+97%0.023+311%
Book Value Per Share--21.24321.004+1%20.437+4%20.176+5%19.944+7%
Current Ratio--14.69310.521+40%10.824+36%10.430+41%7.554+95%
Debt To Asset Ratio--0.0510.076-33%0.066-22%0.067-24%0.067-23%
Debt To Equity Ratio--0.0540.083-35%0.070-23%0.072-25%0.072-25%
Dividend Per Share----0%0.230-100%0.294-100%0.396-100%
Eps--0.1780.180-1%0.309-42%0.154+16%0.188-5%
Free Cash Flow Per Share---0.1930.195-199%0.489-140%0.344-156%0.259-175%
Free Cash Flow To Equity Per Share---0.1930.195-199%0.236-182%0.207-193%0.130-249%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---7.331--------
Intrinsic Value_10Y_min---24.721--------
Intrinsic Value_1Y_max--1.109--------
Intrinsic Value_1Y_min--0.443--------
Intrinsic Value_3Y_max--1.928--------
Intrinsic Value_3Y_min---1.190--------
Intrinsic Value_5Y_max--1.052--------
Intrinsic Value_5Y_min---5.574--------
Market Cap1886257100.000-13%2125445400.0002109549975.000+1%2390369150.000-11%2655061950.000-20%2445417504.034-13%
Net Profit Margin--0.1150.114+0%0.183-37%0.089+30%0.104+10%
Operating Margin----0%0.156-100%0.105-100%0.073-100%
Operating Ratio--1.3751.429-4%1.353+2%1.426-4%1.163+18%
Pb Ratio1.466-13%1.6521.6590%1.934-15%2.182-24%2.027-18%
Pe Ratio43.716-13%49.25948.382+2%35.432+39%81.100-39%83.562-41%
Price Per Share31.150-13%35.10034.838+1%39.475-11%43.845-20%40.378-13%
Price To Free Cash Flow Ratio-40.281+11%-45.388694.327-107%30.131-251%184.428-125%92.852-149%
Price To Total Gains Ratio324.434-13%365.574152.573+140%80.358+355%53.487+583%128.819+184%
Quick Ratio--0.6300.483+30%1.067-41%0.831-24%0.947-33%
Return On Assets--0.0080.008+0%0.014-44%0.007+12%0.009-10%
Return On Equity--0.0080.009-2%0.015-45%0.008+10%0.009-11%
Total Gains Per Share--0.096-0.023+124%0.561-83%0.343-72%0.420-77%
Usd Book Value--39489993.30039046685.300+1%37993468.075+4%37508342.070+5%37082800.160+6%
Usd Book Value Change Per Share--0.003-0.001+124%0.010-71%0.001+97%0.001+311%
Usd Book Value Per Share--0.6520.645+1%0.627+4%0.619+5%0.612+7%
Usd Dividend Per Share----0%0.007-100%0.009-100%0.012-100%
Usd Eps--0.0050.006-1%0.009-42%0.005+16%0.006-5%
Usd Free Cash Flow---359404.900363280.775-199%909548.900-140%639577.705-156%470003.953-176%
Usd Free Cash Flow Per Share---0.0060.006-199%0.015-140%0.011-156%0.008-175%
Usd Free Cash Flow To Equity Per Share---0.0060.006-199%0.007-182%0.006-193%0.004-249%
Usd Market Cap57908092.970-13%65251173.78064763184.233+1%73384332.905-11%81510401.865-20%75074317.374-13%
Usd Price Per Share0.956-13%1.0781.070+1%1.212-11%1.346-20%1.240-13%
Usd Profit--331160.900335228.650-1%574420.025-42%286552.265+16%349869.480-5%
Usd Revenue--2885063.2002932249.100-2%3160227.300-9%3247909.570-11%3339984.243-14%
Usd Total Gains Per Share--0.003-0.001+124%0.017-83%0.011-72%0.013-77%
 EOD+3 -5MRQTTM+20 -12YOY+10 -255Y+20 -1510Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Abnova Taiwan Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1543.716
Price to Book Ratio (EOD)Between0-11.466
Net Profit Margin (MRQ)Greater than00.115
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.630
Current Ratio (MRQ)Greater than114.693
Debt to Asset Ratio (MRQ)Less than10.051
Debt to Equity Ratio (MRQ)Less than10.054
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.008
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Abnova Taiwan Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.491
Ma 20Greater thanMa 5031.238
Ma 50Greater thanMa 10031.883
Ma 100Greater thanMa 20033.536
OpenGreater thanClose31.250
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets1,355,743
Total Liabilities69,424
Total Stockholder Equity1,286,319
 As reported
Total Liabilities 69,424
Total Stockholder Equity+ 1,286,319
Total Assets = 1,355,743

Assets

Total Assets1,355,743
Total Current Assets919,822
Long-term Assets435,921
Total Current Assets
Cash And Cash Equivalents 423,515
Net Receivables 39,432
Inventory 408,302
Other Current Assets 16,983
Total Current Assets  (as reported)919,822
Total Current Assets  (calculated)888,232
+/- 31,590
Long-term Assets
Property Plant Equipment 265,512
Long-term Assets Other 5,244
Long-term Assets  (as reported)435,921
Long-term Assets  (calculated)270,756
+/- 165,165

Liabilities & Shareholders' Equity

Total Current Liabilities62,602
Long-term Liabilities6,822
Total Stockholder Equity1,286,319
Total Current Liabilities
Accounts payable 14,935
Other Current Liabilities 5,790
Total Current Liabilities  (as reported)62,602
Total Current Liabilities  (calculated)20,725
+/- 41,877
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt7,706
Long-term Liabilities  (as reported)6,822
Long-term Liabilities  (calculated)7,706
+/- 884
Total Stockholder Equity
Retained Earnings 107,983
Total Stockholder Equity (as reported)1,286,319
Total Stockholder Equity (calculated)107,983
+/- 1,178,336
Other
Capital Stock605,536
Common Stock Shares Outstanding 60,554
Net Invested Capital 1,286,319
Net Working Capital 857,220
Property Plant and Equipment Gross 265,512



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-09-302009-06-302008-06-30
> Total Assets 
874,050
897,588
919,430
1,309,844
1,360,614
1,306,778
1,334,137
1,372,435
1,393,276
1,302,735
1,355,176
1,368,463
1,381,279
1,280,607
1,292,059
1,325,321
1,332,667
1,267,144
1,285,178
1,298,629
1,318,504
1,269,479
1,307,877
1,300,526
1,280,929
1,222,323
1,248,979
1,254,818
1,262,457
1,239,760
1,248,276
1,267,618
1,290,338
1,322,663
1,303,783
1,291,410
1,293,584
1,257,546
1,294,998
1,295,204
1,304,120
1,269,165
1,263,989
1,269,252
1,265,245
1,288,409
1,294,584
1,288,842
1,308,253
1,265,789
1,283,049
1,298,398
1,291,274
1,333,915
1,374,829
1,376,841
1,411,262
1,366,551
1,355,743
1,355,7431,366,5511,411,2621,376,8411,374,8291,333,9151,291,2741,298,3981,283,0491,265,7891,308,2531,288,8421,294,5841,288,4091,265,2451,269,2521,263,9891,269,1651,304,1201,295,2041,294,9981,257,5461,293,5841,291,4101,303,7831,322,6631,290,3381,267,6181,248,2761,239,7601,262,4571,254,8181,248,9791,222,3231,280,9291,300,5261,307,8771,269,4791,318,5041,298,6291,285,1781,267,1441,332,6671,325,3211,292,0591,280,6071,381,2791,368,4631,355,1761,302,7351,393,2761,372,4351,334,1371,306,7781,360,6141,309,844919,430897,588874,050
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
886,313
890,002
873,305
903,531
869,693
805,810
814,200
778,547
736,032
728,983
738,660
712,776
703,309
714,149
719,347
749,672
773,848
779,291
808,480
773,446
786,290
845,124
838,673
881,536
928,192
928,995
968,402
925,737
919,822
919,822925,737968,402928,995928,192881,536838,673845,124786,290773,446808,480779,291773,848749,672719,347714,149703,309712,776738,660728,983736,032778,547814,200805,810869,693903,531873,305890,002886,313000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
162,647
210,932
206,240
222,660
187,563
130,336
129,391
99,808
145,015
154,476
171,863
156,445
167,240
165,917
187,513
219,264
257,763
263,394
292,925
282,894
306,721
310,660
314,153
360,261
367,065
385,616
424,054
435,071
423,515
423,515435,071424,054385,616367,065360,261314,153310,660306,721282,894292,925263,394257,763219,264187,513165,917167,240156,445171,863154,476145,01599,808129,391130,336187,563222,660206,240210,932162,647000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,900
0
0
0
533
534
0
536
537
538
538
539
540
541
542
542
543
544
544
545
545
546
546
548
849
851
0
0
0
000851849548546546545545544544543542542541540539538538537536053453300058,900000000000000000000000000000000
       Net Receivables 
36,688
47,769
57,897
72,127
76,718
63,891
55,960
77,003
74,881
79,222
68,936
70,418
74,469
70,726
77,859
82,326
72,793
75,329
61,634
69,907
72,884
64,756
57,961
65,769
71,218
67,777
63,562
66,643
67,720
65,276
68,035
80,310
88,160
100,076
105,501
107,066
126,021
130,234
89,398
79,052
82,070
80,414
63,060
69,280
55,522
63,727
50,497
54,633
55,712
44,920
50,368
54,374
59,705
61,198
155,902
43,065
39,385
48,081
39,432
39,43248,08139,38543,065155,90261,19859,70554,37450,36844,92055,71254,63350,49763,72755,52269,28063,06080,41482,07079,05289,398130,234126,021107,066105,501100,07688,16080,31068,03565,27667,72066,64363,56267,77771,21865,76957,96164,75672,88469,90761,63475,32972,79382,32677,85970,72674,46970,41868,93679,22274,88177,00355,96063,89176,71872,12757,89747,76936,688
       Other Current Assets 
20,838
26,409
26,114
36,591
31,473
34,616
31,544
48,880
51,303
56,399
59,427
58,427
57,060
56,829
50,535
7,373
5,117
4,280
4,967
5,720
5,069
5,746
4,692
5,062
5,741
3,545
3,068
5,726
5,031
3,987
5,291
7,501
10,163
8,721
8,519
15,781
765
789
774
385
126
61
679
928
1,274
2,032
1,211
1,329
2,890
2,342
2,330
63,750
54,939
55,462
1,909
632
9,875
11,233
16,983
16,98311,2339,8756321,90955,46254,93963,7502,3302,3422,8901,3291,2112,0321,2749286796112638577478976515,7818,5198,72110,1637,5015,2913,9875,0315,7263,0683,5455,7415,0624,6925,7465,0695,7204,9674,2805,1177,37350,53556,82957,06058,42759,42756,39951,30348,88031,54434,61631,47336,59126,11426,40920,838
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
566,221
565,460
556,389
560,680
555,103
545,898
538,737
520,736
509,551
499,773
492,343
496,759
453,274
452,601
452,379
446,637
447,846
442,860
440,814
435,921
435,921440,814442,860447,846446,637452,379452,601453,274496,759492,343499,773509,551520,736538,737545,898555,103560,680556,389565,460566,221000000000000000000000000000000000000000
       Property Plant Equipment 
118,220
94,242
88,269
75,197
68,943
63,393
60,432
57,870
52,837
53,531
66,535
60,525
56,075
53,067
50,316
45,629
46,435
44,467
50,429
47,424
45,025
46,638
44,043
40,820
38,884
173,675
173,261
171,343
170,823
202,853
225,865
240,916
278,749
274,352
292,758
306,014
302,214
299,052
342,637
350,474
341,671
333,169
330,226
321,539
314,397
312,457
309,901
302,787
294,355
288,098
278,083
272,707
271,457
267,623
267,279
268,076
268,173
266,436
265,512
265,512266,436268,173268,076267,279267,623271,457272,707278,083288,098294,355302,787309,901312,457314,397321,539330,226333,169341,671350,474342,637299,052302,214306,014292,758274,352278,749240,916225,865202,853170,823171,343173,261173,67538,88440,82044,04346,63845,02547,42450,42944,46746,43545,62950,31653,06756,07560,52566,53553,53152,83757,87060,43263,39368,94375,19788,26994,242118,220
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,800
16,622
25,587
33,169
28,151
22,942
22,730
22,118
43,055
45,446
51,957
45,025
44,507
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000044,50745,02551,95745,44643,05522,11822,73022,94228,15133,16925,58716,62218,800000000000000000000000000000000
       Intangible Assets 
61,744
58,113
50,697
42,379
36,729
36,579
32,592
29,645
27,522
29,432
28,799
32,021
33,543
37,115
39,878
8,519
7,983
7,615
7,071
6,528
5,984
5,440
4,896
4,352
3,809
3,357
2,952
2,547
6,027
6,543
6,462
5,869
5,500
5,254
4,957
50,450
48,912
48,403
50,565
50,163
52,227
56,502
69,370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000069,37056,50252,22750,16350,56548,40348,91250,4504,9575,2545,5005,8696,4626,5436,0272,5472,9523,3573,8094,3524,8965,4405,9846,5287,0717,6157,9838,51939,87837,11533,54332,02128,79929,43227,52229,64532,59236,57936,72942,37950,69758,11361,744
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,324
5,650
5,280
5,748
5,871
5,864
6,112
4,043
4,056
4,125
3,873
4,303
4,192
4,170
6,882
11,715
12,748
9,358
10,524
5,244
5,24410,5249,35812,74811,7156,8824,1704,1924,3033,8734,1254,0564,0436,1125,8645,8715,7485,2805,6505,324000000000000000000000000000000000000000
> Total Liabilities 
152,207
95,783
97,972
57,250
151,646
56,897
64,239
63,359
180,002
61,145
84,508
70,435
186,928
68,043
63,122
72,709
131,681
50,645
55,421
55,136
128,259
62,841
78,153
70,130
133,318
64,902
82,352
73,849
107,612
78,014
72,059
82,528
101,987
106,665
79,053
71,639
110,023
67,261
67,766
66,039
102,473
76,093
71,586
76,156
69,717
82,121
83,490
108,322
122,823
68,191
71,293
94,685
78,200
92,407
82,835
123,487
143,924
86,046
69,424
69,42486,046143,924123,48782,83592,40778,20094,68571,29368,191122,823108,32283,49082,12169,71776,15671,58676,093102,47366,03967,76667,261110,02371,63979,053106,665101,98782,52872,05978,014107,61273,84982,35264,902133,31870,13078,15362,841128,25955,13655,42150,645131,68172,70963,12268,043186,92870,43584,50861,145180,00263,35964,23956,897151,64657,25097,97295,783152,207
   > Total Current Liabilities 
144,213
91,319
93,889
55,307
150,032
55,372
63,277
62,450
179,963
60,607
84,169
69,991
186,658
67,768
63,122
72,709
131,681
50,645
55,421
55,136
128,259
62,841
78,148
69,861
133,125
64,742
82,138
73,661
107,386
77,732
71,022
81,471
100,987
105,741
77,819
70,385
108,739
65,982
66,739
55,057
93,866
69,370
64,298
70,355
65,324
76,620
74,574
100,311
116,315
62,752
62,726
93,547
73,135
87,724
72,819
113,831
134,565
76,945
62,602
62,60276,945134,565113,83172,81987,72473,13593,54762,72662,752116,315100,31174,57476,62065,32470,35564,29869,37093,86655,05766,73965,982108,73970,38577,819105,741100,98781,47171,02277,732107,38673,66182,13864,742133,12569,86178,14862,841128,25955,13655,42150,645131,68172,70963,12267,768186,65869,99184,16960,607179,96362,45063,27755,372150,03255,30793,88991,319144,213
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
290
310
340
0
0
118
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001180034031029010,000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
290
310
340
0
0
118
0
0
0
0
0
171
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000171000001180034031029010,000000000000000000000000000000000000
       Accounts payable 
52,250
14,267
14,166
13,731
16,976
11,453
11,208
9,863
13,030
13,216
12,531
12,361
13,621
11,216
15,277
18,456
14,496
10,974
12,786
12,686
12,585
12,498
19,107
15,674
17,877
12,056
20,470
12,802
12,992
11,453
15,487
18,577
17,991
11,804
14,971
15,681
17,278
14,666
16,199
9,134
13,625
14,359
10,951
13,484
10,948
25,285
16,957
11,629
24,209
13,446
11,480
14,015
14,430
12,859
14,995
15,560
17,509
16,506
14,935
14,93516,50617,50915,56014,99512,85914,43014,01511,48013,44624,20911,62916,95725,28510,94813,48410,95114,35913,6259,13416,19914,66617,27815,68114,97111,80417,99118,57715,48711,45312,99212,80220,47012,05617,87715,67419,10712,49812,58512,68612,78610,97414,49618,45615,27711,21613,62112,36112,53113,21613,0309,86311,20811,45316,97613,73114,16614,26752,250
       Other Current Liabilities 
43,331
38,052
40,723
41,576
133,056
43,919
52,069
52,587
166,933
47,391
71,638
57,630
173,037
56,552
47,845
54,253
117,185
39,671
42,635
42,450
115,674
50,343
59,041
54,187
115,248
52,686
61,668
60,859
94,394
66,279
55,535
62,894
82,996
83,937
62,848
54,704
91,461
51,316
50,540
2,942
3,261
2,955
42,470
47,233
46,371
41,518
46,859
78,623
83,514
40,555
44,254
73,611
53,939
69,931
50,625
4,388
4,749
5,189
5,790
5,7905,1894,7494,38850,62569,93153,93973,61144,25440,55583,51478,62346,85941,51846,37147,23342,4702,9553,2612,94250,54051,31691,46154,70462,84883,93782,99662,89455,53566,27994,39460,85961,66852,686115,24854,18759,04150,343115,67442,45042,63539,671117,18554,25347,84556,552173,03757,63071,63847,391166,93352,58752,06943,919133,05641,57640,72338,05243,331
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,982
8,607
6,723
7,288
5,801
4,393
5,501
8,916
8,011
6,508
5,439
8,567
1,138
5,065
4,683
10,016
9,656
9,359
9,101
6,822
6,8229,1019,3599,65610,0164,6835,0651,1388,5675,4396,5088,0118,9165,5014,3935,8017,2886,7238,60710,982000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-10,000
-290
-310
-340
0
0
20,657
18,062
15,127
17,700
14,949
11,911
14,891
16,060
14,375
11,406
10,441
7,552
6,477
9,188
8,989
10,885
8,724
6,767
5,068
7,706
7,7065,0686,7678,72410,8858,9899,1886,4777,55210,44111,40614,37516,06014,89111,91114,94917,70015,12718,06220,65700-340-310-290-10,000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
394
341
445
465
490
487
427
3,614
3,695
3,694
3,749
8,007
582
643
628
526
496
450
443
438
4384434504965266286435828,0073,7493,6943,6953,614427487490465445341394000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,971
26,721
23,317
20,946
20,110
17,137
14,857
14,386
12,136
10,646
9,787
12,245
12,605
13,757
13,043
0
12,222
11,425
11,783
11,430
11,043
10,178
11,358
12,825
14,608
14,630
13,181
0
0
0013,18114,63014,60812,82511,35810,17811,04311,43011,78311,42512,222013,04313,75712,60512,2459,78710,64612,13614,38614,85717,13720,11020,94623,31726,72128,971000000000000000000000000000000
> Total Stockholder Equity
721,843
801,805
821,458
1,252,594
1,208,968
1,249,881
1,269,898
1,309,076
1,213,274
1,241,590
1,270,668
1,298,028
1,194,351
1,212,564
1,228,937
1,252,612
1,200,986
1,216,499
1,229,757
1,243,493
1,190,245
1,206,638
1,229,724
1,230,396
1,147,611
1,157,421
1,166,627
1,180,969
1,154,845
1,161,746
1,176,217
1,185,090
1,188,351
1,215,998
1,224,730
1,219,771
1,183,561
1,190,285
1,227,232
1,229,165
1,201,647
1,193,072
1,192,403
1,193,096
1,195,528
1,206,288
1,211,094
1,180,520
1,185,430
1,197,598
1,211,756
1,203,713
1,213,074
1,241,508
1,291,994
1,253,354
1,267,338
1,280,505
1,286,319
1,286,3191,280,5051,267,3381,253,3541,291,9941,241,5081,213,0741,203,7131,211,7561,197,5981,185,4301,180,5201,211,0941,206,2881,195,5281,193,0961,192,4031,193,0721,201,6471,229,1651,227,2321,190,2851,183,5611,219,7711,224,7301,215,9981,188,3511,185,0901,176,2171,161,7461,154,8451,180,9691,166,6271,157,4211,147,6111,230,3961,229,7241,206,6381,190,2451,243,4931,229,7571,216,4991,200,9861,252,6121,228,9371,212,5641,194,3511,298,0281,270,6681,241,5901,213,2741,309,0761,269,8981,249,8811,208,9681,252,594821,458801,805721,843
   Common Stock
540,579
541,579
541,579
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
595,469
580,469
580,469
580,469
580,469
587,899
587,899
587,899
587,899
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
605,536
0
0
0
0
0000605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536605,536587,899587,899587,899587,899580,469580,469580,469580,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469595,469541,579541,579540,579
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000-48,409000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,737
-6,721
11,907
-4,846
-4,908
-3,250
-3,947
-7,086
15,028
18,830
25,141
16,022
14,068
13,120
11,430
7,243
992
-3,012
-5,019
-5,966
9,229
11,751
2,249
3,811
-11,907
0
0
0
0
0000-11,9073,8112,24911,7519,229-5,966-5,019-3,0129927,24311,43013,12014,06816,02225,14118,83015,028-7,086-3,947-3,250-4,908-4,84611,907-6,721-3,737000000000000000000000000000000



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue382,052
Cost of Revenue-208,137
Gross Profit173,915173,915
 
Operating Income (+$)
Gross Profit173,915
Operating Expense-337,911
Operating Income44,141-163,996
 
Operating Expense (+$)
Research Development38,396
Selling General Administrative91,378
Selling And Marketing Expenses0
Operating Expense337,911129,774
 
Net Interest Income (+$)
Interest Income10,528
Interest Expense-142
Other Finance Cost-0
Net Interest Income10,386
 
Pretax Income (+$)
Operating Income44,141
Net Interest Income10,386
Other Non-Operating Income Expenses0
Income Before Tax (EBT)48,51744,141
EBIT - interestExpense = -142
43,678
43,820
Interest Expense142
Earnings Before Interest and Taxes (EBIT)048,659
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax48,517
Tax Provision-4,839
Net Income From Continuing Ops43,67843,678
Net Income43,678
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-10,386
 

Technical Analysis of Abnova
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Abnova. The general trend of Abnova is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Abnova's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Abnova Taiwan Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 31.30 < 32.35 < 32.60.

The bearish price targets are: 29.80.

Tweet this
Abnova Taiwan Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Abnova Taiwan Corp. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Abnova Taiwan Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Abnova Taiwan Corp. The current macd is -0.37860492.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Abnova price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Abnova. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Abnova price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Abnova Taiwan Corp Daily Moving Average Convergence/Divergence (MACD) ChartAbnova Taiwan Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Abnova Taiwan Corp. The current adx is 19.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Abnova shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Abnova Taiwan Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Abnova Taiwan Corp. The current sar is 29.80.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Abnova Taiwan Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Abnova Taiwan Corp. The current rsi is 47.49. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Abnova Taiwan Corp Daily Relative Strength Index (RSI) ChartAbnova Taiwan Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Abnova Taiwan Corp. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Abnova price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Abnova Taiwan Corp Daily Stochastic Oscillator ChartAbnova Taiwan Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Abnova Taiwan Corp. The current cci is -5.72483841.

Abnova Taiwan Corp Daily Commodity Channel Index (CCI) ChartAbnova Taiwan Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Abnova Taiwan Corp. The current cmo is 5.2010385.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Abnova Taiwan Corp Daily Chande Momentum Oscillator (CMO) ChartAbnova Taiwan Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Abnova Taiwan Corp. The current willr is -42.55319149.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Abnova is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Abnova Taiwan Corp Daily Williams %R ChartAbnova Taiwan Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Abnova Taiwan Corp.

Abnova Taiwan Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Abnova Taiwan Corp. The current atr is 0.50440235.

Abnova Taiwan Corp Daily Average True Range (ATR) ChartAbnova Taiwan Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Abnova Taiwan Corp. The current obv is 135,118,807.

Abnova Taiwan Corp Daily On-Balance Volume (OBV) ChartAbnova Taiwan Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Abnova Taiwan Corp. The current mfi is 45.34.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Abnova Taiwan Corp Daily Money Flow Index (MFI) ChartAbnova Taiwan Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Abnova Taiwan Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Abnova Taiwan Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Abnova Taiwan Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.491
Ma 20Greater thanMa 5031.238
Ma 50Greater thanMa 10031.883
Ma 100Greater thanMa 20033.536
OpenGreater thanClose31.250
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Abnova with someone you think should read this too:
  • Are you bullish or bearish on Abnova? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Abnova? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Abnova Taiwan Corp

I send you an email if I find something interesting about Abnova Taiwan Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Abnova Taiwan Corp.

Receive notifications about Abnova Taiwan Corp in your mailbox!